Saturday, Dec 15 2018 | Time 12:25 Hrs(IST)
  • World Bank announces new US $140 mn grant for Yemen
  • Situation continued to be grim with more than 80 persons still undergoing treatment due to food poisoning in which 11 people died yesterday
  • Two killed, several injured in security force action in Pulwama
  • Cong says govt misled SC on Rafale, reiterates demand for JPC probe
  • Sensex rises by 289 68 points this weekend
  • How 'Xiplomacy' pushes change in global governance
  • Train service suspended in Kashmir
  • PM Modi to visit Congress' stronghold Rae Bareli o Sunday
  • 16-year-old Wang Jianjiehe becomes new hope of Chinese swimming
  • Rafale makers Dassault backs Modi’s 'Make in India' push; welcomes SC Court verdict
  • Temple food poisoning incident: Situation grim with over 80 suffering in hospitals
  • Mughal road remains shut for 6th day, Kashmir highway through for one-way only
  • Sealed US court files suggest Russian citizen Butina may testify in another Case: Reports
  • Supreme Court verdict on Rafale has given 'lifeline' to BJP, says BJD leader Mahtab
  • Italian economic offender to be extradited from Brazil
Business Economy Share

Alembic Pharma gets tentative USFDA nod for Ticagrelor tablets

Alembic Pharma gets tentative USFDA nod for Ticagrelor tablets

Mumbai, Jul 12 (UNI) Pharma Major, Alembic Pharmaceuticals said that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abberivated New Drug Application

(ANDA) Ticagrelor tablets 90 mg.

The tentatively approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to the reference listed drug product (RLD), Brilinta tablets of Astrazeneca Pharmaceuticals LP.

It is used to reduce the rate of cardiovascular death and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI).

Quoting IQVIA sales data, the company said, Ticagrelor tablets, 90 mg had an estimated market size of USD625 million for 12 months, ending December 2017.

The company said it now has a total of 75 ANDA approvals from the USFDA.


More News
Sensex rises by 289 68 points this weekend

Sensex rises by 289 68 points this weekend

15 Dec 2018 | 12:10 PM

Mumbai, Dec 15(UNI) The BenchMark Index of Bombay Stock Exchange(BSE) rose 289.68 points or 0.81 per cent to settle at 35,962.93 in the highly volatile week under review, following strong domestic economic data.

 Sharesee more..
Bullion Market Opening rates

Bullion Market Opening rates

15 Dec 2018 | 12:09 PM

Chennai, Dec 15 (UNI) Following is the bullion markets
opening rate here today.

 Sharesee more..
USD up; Euro, Pound, yen down

USD up; Euro, Pound, yen down

15 Dec 2018 | 12:08 PM

Mumbai, Dec 15 (UNI) Following were the indicative currency rates and travellers' cheques buying and selling rates per unit.

 Sharesee more..

15 Dec 2018 | 12:01 PM

ONGC rose 5.

 Sharesee more..

Chennai Oil Market Rates

15 Dec 2018 | 11:35 AM

Chennai, Dec 15 (UNI) Following are the rates in the
Chennai Oil Market here today.

 Sharesee more..